Former FDA chief counsel Dan Troy discusses the motivation behind potential DTC pharma ad bans.
Dan Troy
Advertisement
Dan Troy is a former lead counsel for FDA.
Articles by Dan Troy
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Navigating Turbulent Markets: What Two Decades in Biotech Finance Taught Me About Building Companies That Last
2
FDA Approves Hepcludex as First and Only Approved Treatment for Chronic Hepatitis Delta Virus
3
Eli Lilly Enters Three Separate Acquisitions Totaling $3.83 Billion
4
How Do You Think Ai Can Improve FDA's Internal Process?
5